L-arginine protects human heart cells from low-volume anoxia and reoxygenation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 282, Issue 3 51-3, 2002, Pages

  Shiono, Noritsugu ^a   Rao, Vivek ^a   Weisel, Richard D ^a   Kawasaki, Muneyasu ^a   Li, Ren Ke ^a   Mickle, Donald A G ^a   Fedak, Paul W M ^a   Tumiati, Laura C ^a   Ko, Lawrence ^a   Verma, Subodh ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiac surgery; Nitric oxide; Ventricular myocytes

Indexed keywords

ARGININE; NITRIC OXIDE;

ANOXIA; ARTICLE; CELL PROTECTION; CELL TYPE; ELECTRON TRANSPORT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; HEART SURGERY; HUMAN; HUMAN CELL; LUNG VOLUME; POTASSIUM CURRENT; PRIORITY JOURNAL; REOXYGENATION;

EID: 0036088653     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00594.2001     Document Type: Article

References (45)

1. L-arginine reverses low coronary reflow and enhances postanoxic recovery of cardiac mechanical function
2. Myocyte mitotic division in the aging mammalian rat heart
3. Measurement of nitric oxide in biological models
4. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by c-GMP dependent protein kinase
5. Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthases
6. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure
7. Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart
8. Optimal myocardial preconditioning in a human model of low-volume ischemia and reperfusion
9. Nitric oxide synthase activities in human myocardium
10. Modulation of endothelin-1 effects on rat hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic-GMP
11. Constitutive nitric oxide release is impaired after low-volume ischemia and reperfusion
12. An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus
13. Cardioprotection from ischemia and reperfusion injury by an endothelin-A receptor antagonist in relation to nitric oxide production
14. Nitric oxide regulation of superoxide-dependent lung injury: Oxidant-protective actions of endogenously produced and exogenously administered nitric oxide
15. Adequate distribution of warm cardioplegic solution
16. Tepid antegrade and retrograde cardioplegia
17. Effect of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia
18. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C
19. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia
20. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of function in adult rat ventricular myocytes
21. Human pediatric and adult ventricular cardiomyocytes in culture: Assessment of phenotypic changes with passaging
22. Methods of culturing cardiomyocytes from human pediatric ventricular myocardium
23. Lactate accumulation in isolated hypoxic rat ventricular myocardium: Effect of different modulators of the cyclic GMP system
24. Proliferating cell nuclear antigen in developing and adult rat cardiac muscle cells
25. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase
26. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size
27. ATP channel induces early and delayed cardioprotective effect: Role of nitric oxide
28. An endogenous protectant effect of cardiac cyclic GMP against reperfusion-induced ventricular fibrillation in the rat heart
29. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo
30. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia
31. Agonist-modulated palmitoylation of endothelial nitric oxide synthase
32. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting
33. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postanoxic injury
34. Regulation and subcellular location of nitrogen oxide syntheses in RAW 264.7 macrophages
35. Determination of nitric oxide via measurement of nitrite and nitrate in culture media
36. Lack of tolerance to a 24-h infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits
37. Preconditioning human cardiomyocytes and endothelial cells
38. Antegrade and retrograde cardioplegia: Alternate or simultaneous?
39. Cyclic-GMP inhibits the activity of single calcium channels in embryonic chick heart cells
40. 2+ channel activity by human natriuretic peptide in rabbit heart cells
41. An in vitro model to study myocardial anoxic injury
42. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists
43. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts
44. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the anoxic feline myocardium
45. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat